QuidelOrtho
QDEL
#3844
Rank
โ‚ฌ2.42 B
Marketcap
36,12ย โ‚ฌ
Share price
1.09%
Change (1 day)
-42.11%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

Revenue for QuidelOrtho (QDEL)

Revenue in 2024 (TTM): โ‚ฌ2.62 Billion

According to QuidelOrtho's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.70 Billion. In 2023 the company made a revenue of โ‚ฌ2.71 Billion a decrease over the revenue in the year 2022 that were of โ‚ฌ3.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for QuidelOrtho from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ2.62 B-3.12%
2023 โ‚ฌ2.71 B-10.93%
2022 โ‚ฌ3.04 B103%
2021 โ‚ฌ1.49 B11.02%
2020 โ‚ฌ1.35 B182.93%
2019 โ‚ฌ0.47 B4.59%
2018 โ‚ฌ0.45 B97.23%
2017 โ‚ฌ0.23 B27.08%
2016 โ‚ฌ0.18 B1.55%
2015 โ‚ฌ0.17 B19.24%
2014 โ‚ฌ0.15 B18.43%
2013 โ‚ฌ0.12 B7.88%
2012 โ‚ฌ0.11 B-3.59%
2011 โ‚ฌ0.12 B43.33%
2010 โ‚ฌ85.2 M-25.69%
2009 โ‚ฌ0.11 B25.11%
2008 โ‚ฌ91.65 M13.35%
2007 โ‚ฌ80.86 M0.64%
2006 โ‚ฌ80.34 M3.12%
2005 โ‚ฌ77.91 M36.04%
2004 โ‚ฌ57.27 M-24.18%
2003 โ‚ฌ75.53 M3.53%
2002 โ‚ฌ72.96 M-11.96%
2001 โ‚ฌ82.87 M15.55%
2000 โ‚ฌ71.72 M
1998 โ‚ฌ41.62 M9.05%
1997 โ‚ฌ38.17 M16.75%
1996 โ‚ฌ32.69 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.31 B-88.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.90 B 599.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ40.37 B 1,393.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.26 B-90.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.09 B 606.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.20 B 18.45%๐Ÿ‡บ๐Ÿ‡ธ USA